Anti-coagulant aptamers

Thrombosis Research

Volumn 122, Issue 6, 2008, Pages 838-847

  Gopinath, Subash Chandra Bose ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APTAMER; BLOOD CLOTTING FACTOR 9; THROMBIN;

BLOOD CLOTTING; BLOOD VESSEL INJURY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION;

ANIMALS; ANTICOAGULANTS; ANTITHROMBINS; APTAMERS, NUCLEOTIDE; BLOOD COAGULATION; FACTOR IX; FACTOR VIIA; HUMANS; PROTEIN C INHIBITOR; SELEX APTAMER TECHNIQUE;

EID: 52049111643     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.10.022     Document Type: Review

References (42)

1. Gopinath S.C.B. Methods developed for SELEX. Anal Bioanal Chem 387 (2007) 171-182
2. Warkentin T.E., and Greinacher A. Heparin-induced throbocytopenia and cardiac surgery. Ann Thorac Surg 76 (2003) 2121-2131
3. Adler B.K. Unfractionated heparin and other antithrombin mediated anticoagulants. Clin Lab Sci 17 (2004) 113-117
4. Gopinath S.C.B., Shikamoto Y., Mizuno H., and Kumar P.K.R. Snake venom-derived factor IX binding protein specifically blocks the Gla domain-mediated-membrane binding of human factors IX and X. Biochem J 405 (2007) 351-357
5. Gopinath S.C.B., Shikamoto Y., Mizuno H., and Kumar P.K.R. A potent anti-coagulant RNA aptamer inhibits blood coagulation by blocking specifically an extrinsic clotting pathway. Thromb Haemost 95 (2006) 767-771
6. Rusconi C.P., Yeh A., Lyerly H.K., Lawson J.H., and Sullenger B.A. Blocking the initiation of coagulation by RNA aptamers to factor VIIa. Thromb Haemost 84 (2000) 841-848
7. Bock L.C., Griffin L.C., Latham J.A., Vermaas E.H., and Toole J.J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355 (1992) 564-566
8. Tasset D.M., Kubik M.F., and Steiner W. Oligonucleotide inhibitors of human thrombin that distinct epitopes. J Mol Biol 272 (1997) 688-698
9. Padmanabhan K., Padmanabhan K.P., Ferrara J.D., Sadler J.E., and Tulinky A. The structure of α-thrombin inhibited by a 15-mer single-stranded DNA aptamer. J Biol Chem 268 (1993) 17651-17654
10. Li W., Kaplan A.V., Grant G.W., Toole J.J., and Leung L.L.K. A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation. Blood 83 (1994) 677-682
11. Latham J.A., Johnson R., and Toole J.J. The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2′-deoxyuridine. Nucleic Acids Res 22 (1994) 2817-2822
12. Kubik M.F., Stephens A.W., Schneider D., Marlar R.A., and Tasset D. High-affinity RNA ligands to human α-thrombin. Nuclei Acids Res 22 (1994) 2619-2626
13. Holland C.A., Henry A.T., Whinna H.C., and Church F.C. Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin. FEBS Lett 484 (2000) 87-91
14. Martino L., Virno A., Randazzo A., Virgilio A., Esposito V., and Giancola C. A new modified thrombin binding aptamer containing a 5′-5′ inversion of polarity site. Nucleic Acids Res 34 (2006) 6653-6662
15. Kato Y., Minakawa N., Komatsu Y., Kamiya H., Ogawa N., and Harashima H. New NTP analogs: the synthesis of 4′-thioUTP and 4′-thioCTP and their utility for SELEX. Nucleic Acids Res 33 (2005) 2942-2951
16. Rusconi C.P., Scardino E., Layzer J., Pitoc G.A., Ortel T.L., and Monroe D. RNA aptamers as reversible antagonists of coagulation factor IXa. Nature 419 (2002) 90-94
17. Chen S.W., Pellequer J.L., Schved J.F., and Giansily-Blaizot M. Model of a ternary complex between activated factor VII, tissue factor and factor IX. Thromb Haemost 88 (2000) 74-82
18. Schmidt A.E., and Bajaj S.P. Structure-function relationships in factor IX and factor IXa. Trends Cardiovasc Med 13 (2003) 39-45
19. Gal S.W., Amontov S., Urvil P.T., Vishnuvardhan D., Nishikawa F., and Kumar P.K.R. Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function. Eur J Biochem 252 (1998) 553-562
20. Jenison R.D., Gill S.C., Pardi A., and Polisky B. High-resolution molecular discrimination by RNA. Science 263 (1994) 1425-1429
21. Liu X.M., Zhang D., Cao G., Yang G., Ding H., and Liu G. RNA aptamers specific for bovine thrombin. J Mol Recognit 16 (2003) 23-27
22. Liu X.M., Cao G., Ding H., Zhang D., Yang G., and Liu N. Screening of functional antidotes of RNA aptamers against bovine thrombin. FEBS Lett 562 (2004) 125-128
23. Gopinath S.C.B., Balasundaresan D., Akitomi J., and Mizuno H. An RNA aptamer that discriminates bovine factor IX from human factor IX. J Biochem 140 (2006) 667-676
24. Rusconi C.P., Roberts J.D., Pitoc G.A., Nimjee S.M., White R.R., and Quick G. Antidote-mediated control of an anticoagulant aptamer in vivo. Nature Biotechnol 22 (2004) 1423-1428
25. Heckel A., Buff M.C., Raddatz M.S., Muller J., Potzsch B., and Mayer G. An anticoagulant with light-triggered antidote activity. Angew Chem Int Ed Engl 45 (2006) 6748-6750
26. Joachimi A., Mayer G., and Hartig J.S. A new anticoagulant-antidote pair: control to thrombin activity by aptamers and Porphyrins. J Am Chem Soc 129 (2007) 3036-3037
27. Tombelli S., Minunni M., and Mascini M. Analytical applications of aptamers. Biosens Bioelectron 20 (2005) 2424-2434
28. Chu T.C., Marks III J.W., Lavery L.A., Faulkner S., Rosenblum M.G., Ellington A.D., et al. Aptamer: toxin conjugates that specifically target prostate tumor cells. Cancer Res 66 (2006) 5989-5992
29. Yamamoto-Fujita R., and Kumar P.K.R. Aptamer-derirved nucleic acid oligos: applications to develop nucleic acid chips to analyze proteins and small ligands. Anal Chem 77 (2005) 5460-5466
30. Monroe D.M., Hoffman M., and Roberts H.R. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 22 (2002) 1381-1389
31. Becker R.C., Rusconi C., and Sullenger B. Nucleic acid aptamers in therapeutic anticoagulation. Technology, development and clinical application. Thromb Haemost 93 (2005) 1014-1020
32. Gronewold T.M.A., Glass S., Quandt E., and Famulok M. Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors. Biosen Bioelectron 20 (2005) 2044-2052
33. Heckel A., and Mayer G. Light regulation of aptamer activity: an anti-thrombin aptamer with caged thymidine nucleobases. J Am Chem Soc 127 (2005) 822-823
34. Ikebukuro K., Kiyohara C., and Sode K. Novel electrochemical sensor system for protein using the aptamers in sandwich manner. Biosen Bioelectron 20 (2005) 2168-2172
35. Balamurugan S., Obubuafo A., Soper S.A., McCarley R.L., and Spivak D.A. Designing highly specific biosensing surfaces using aptamer monolayers on gold. Langmuir 22 (2006) 6446-6453
36. Polsky R., Gill R., Kaganovsky L., and Willner I. Nucleic acid-functionalized Pt naoparticles: catalytic labels for the amplified electrochemical detection of biomolecules. Anal Chem 78 (2006) 2268-2271
37. Lai R.Y., Plaxco K.W., and Heeger A. Aptamer-based electrochemical detection of picomolar platelet-derived growth factor directly in blood serum. Anal Chem 79 (2007) 229-233
38. Mendonsa S.D., and Bowser M.T. In vitroselection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal Chem 76 (2004) 5387-5392
39. Lee J.F., Stovall G.M., and Ellington A.D. Aptamer therapeutics advance. Curr Opin Chem Biol 10 (2006) 282-289
40. Griffin L.C., Tidmarsh G.F., Bock L.C., Toole J.J., and Leung L.L.K. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulant in extracorporeal circuits. Blood 81 (1993) 3271-3276
41. Dyke C.K., Steinhubl S.R., Kleiman N.S., Cannon R.O., Aberle L.G., and Lin M. First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity. Circulation 114 (2006) 2490-2497
42. Nimjee S.M., Rusconi C.P., and Sullenger B.A. Aptamers: an emerging class of therapeutics. Annu Rev Med 56 (2005) 555-583